Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05149573 · ClinicalTrials.gov registry record · NA

Investigation of PEMF Therapy for Female Patients With IC/BPS

A NA study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05149573 is a NA study of Interstitial Cystitis and Bladder Pain Syndrome that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 75 participants, below the 359-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05149573, a NA study of Interstitial Cystitis and Bladder Pain Syndrome, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease bladder and pelvic pain as well as other urinary symptoms associated with IC/BPS. There are two sequential Aims in this study and subjects will be recruited to participate in only one Aim. In both Aims, data will be collected at baseline/enrollment, 4-weeks after using PEMF therapy, and 8, 12, and 16 weeks post-enrollment.

Interventions

  • DEVICE Pulsed Electromagnetic Field (PEMF) Device
  • DEVICE Sham Pulsed Electromagnetic Field (PEMF) Device

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-08-29
Est. Completion 2026-04
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05149573

The ClinicalTrials.gov registry entry for NCT05149573 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 359-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (79% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Pulsed Electromagnetic Field (PEMF) Device is the first listed.

NCT05149573 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05149573 about?

NCT05149573 is a clinical study titled "Investigation of PEMF Therapy for Female Patients With IC/BPS". The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cy...

What is the current status of trial NCT05149573?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-08-29. Estimated completion is 2026-04.

What conditions does trial NCT05149573 study?

This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome, Chronic Interstitial Cystitis.

What interventions are being tested in trial NCT05149573?

The interventions under investigation include: Pulsed Electromagnetic Field (PEMF) Device (DEVICE), Sham Pulsed Electromagnetic Field (PEMF) Device (DEVICE).

Who is sponsoring clinical trial NCT05149573?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05149573 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Interstitial Cystitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.